Kevin O’Leary: Two AI Opportunities to Watch in 2023

Shark Tank investor Kevin O’Leary has highlighted two AI-driven sectors he believes hold significant potential for entrepreneurs, according to recent interviews. The billionaire venture capitalist, known for his sharp market insights, emphasized the importance of focusing on AI applications with clear scalability and demand, citing generative AI tools and AI-driven healthcare innovations as key areas.

Why Generative AI Remains a Hot Investment

Generative AI, which includes tools like large language models and AI-powered content creation software, continues to attract substantial funding. According to a July 2023 report by PitchBook, global venture capital investment in AI startups reached $54 billion in the first half of 2023, with generative AI companies securing over 30% of those funds. O’Leary, who has publicly invested in AI ventures, told Forbes in June 2023 that the technology’s ability to “redefine productivity” makes it a compelling opportunity for young entrepreneurs.

AI in Healthcare: A Growing Frontier

O’Leary also pointed to AI applications in healthcare as a critical area for growth. The sector has seen a surge in AI-driven diagnostics, personalized treatment planning, and drug discovery. A June 2023 study published in JAMA Internal Medicine found that AI algorithms now match or exceed human accuracy in detecting conditions like breast cancer and diabetic retinopathy. “Healthcare is a $10 trillion industry,” O’Leary said in a July 2023 podcast interview. “AI is already cutting costs and improving outcomes—this is just the beginning.”

What Sets These Opportunities Apart?

Unlike earlier AI hype cycles, current investments focus on tangible use cases with measurable returns. For example, generative AI tools like ChatGPT and MidJourney have been adopted by over 70% of Fortune 500 companies, according to a July 2023 Gartner survey. Meanwhile, AI-powered medical devices are receiving faster regulatory approvals. The U.S. Food and Drug Administration (FDA) approved 22 AI-based diagnostics in 2022, a 40% increase from 2021, per Healthcare Dive.

Challenges and Risks to Consider

Despite the optimism, experts caution that both sectors face regulatory and ethical hurdles. The European Union’s AI Act, set to take effect in 2024, could impose strict requirements on generative AI systems. In healthcare, concerns over data privacy and algorithmic bias remain unresolved. “These opportunities are real, but they require careful execution,” said Dr. Sarah Lin, a tech policy researcher at Stanford University, in a July 2023 interview.

What’s Next for AI Entrepreneurs?

For founders, O’Leary advises focusing on niche markets where AI can deliver immediate value. “Don’t try to solve the whole world,” he said in a July 2023 LinkedIn post. “Find a specific problem and build a tool that makes a measurable difference.” As AI adoption accelerates, the companies that succeed will likely be those that balance innovation with practicality.